Levy R A, Avvad E, Oliveira J, Porto L C
Departamento de Anatomia Patológica, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Brazil.
Lupus. 1998;7 Suppl 2:S81-5. doi: 10.1177/096120339800700218.
One of the major targets of antiphospholipid antibodies (aPL) is the placenta, the evolution of which during pregnancy has been well documented. Histopathological findings are related to gestational age, and several physiologic and pathologic alterations that occur during its development. The major findings in placentae from aPL positive patients are thrombosis, acute atherosis, a decreased number of syncytio-vascular membranes, increased number of syncytial knots and obliterative arteriopathy. These findings are not specific to the antiphospholipid syndrome (APS) and sometimes do not correlate with the fetal outcome. Histopathological study of placentae may elucidate mechanisms of action of aPL in fetal loss and other obstetric complications. In addition, it may assist in the investigation of the differential diagnosis between APS and pregnancy-induced hypertension. Immunohistochemical studies of local placental proteins contribute to this differential diagnosis.
抗磷脂抗体(aPL)的主要靶标之一是胎盘,其在妊娠期间的演变已有充分记录。组织病理学发现与孕周以及胎盘发育过程中发生的一些生理和病理改变有关。aPL阳性患者胎盘的主要发现是血栓形成、急性动脉粥样硬化、合体滋养层-血管膜数量减少、合体结节数量增加以及闭塞性动脉病。这些发现并非抗磷脂综合征(APS)所特有,有时与胎儿结局并无关联。胎盘的组织病理学研究可能会阐明aPL在胎儿丢失及其他产科并发症中的作用机制。此外,它可能有助于APS与妊娠高血压综合征之间的鉴别诊断研究。胎盘局部蛋白的免疫组织化学研究有助于这种鉴别诊断。